SecSonar.com

NeuroOne Medical Technologies Corporation (NMTC)

NeuroOne Medical Technologies Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

NeuroOne Medical Technologies Corporation (NMTC) is a Medical - Devices company based in US with a market capitalization of $32.5M. Revenue grew 250.3% year-over-year and free cash flow was negative at -$2.9M. This page tracks NMTC's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 17 employees · IPO Mar 15, 2018

Valuation

Valuation & price

$4.21 · as of May 17, 2026 · -33.8% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

4.60

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$6.24$4.62$3.00Jul 25Dec 25Jul 26Jul 7, 25$4.39Jul 9, 25$4.44Jul 11, 25$4.27Jul 15, 25$4.23Jul 17, 25$4.53Jul 21, 25$5.40Jul 23, 25$5.39Jul 25, 25$5.32Jul 29, 25$5.01Jul 31, 25$4.69Aug 4, 25$4.94Aug 6, 25$4.80Aug 11, 25$4.43Aug 13, 25$5.16Aug 15, 25$4.92Aug 19, 25$4.85Aug 21, 25$4.62Aug 25, 25$4.68Aug 27, 25$4.50Aug 29, 25$4.59Sep 3, 25$4.46Sep 5, 25$4.76Sep 9, 25$5.36Sep 11, 25$5.37Sep 16, 25$5.35Sep 18, 25$5.40Sep 22, 25$5.59Sep 24, 25$5.64Sep 26, 25$5.51Sep 30, 25$5.33Oct 2, 25$5.40Oct 6, 25$5.97Oct 8, 25$6.24Oct 10, 25$5.70Oct 14, 25$5.44Oct 16, 25$5.18Oct 21, 25$4.92Oct 23, 25$4.77Oct 27, 25$5.01Oct 29, 25$4.71Oct 31, 25$4.75Nov 4, 25$4.34Nov 6, 25$4.31Nov 10, 25$4.24Nov 12, 25$4.40Nov 14, 25$4.14Nov 18, 25$3.84Nov 20, 25$3.61Nov 25, 25$4.10Nov 28, 25$4.17Dec 2, 25$3.97Dec 4, 25$4.03Dec 8, 25$3.93Dec 10, 25$3.60Dec 12, 25$3.94Dec 16, 25$4.24Dec 18, 25$4.30Dec 22, 25$4.82Dec 24, 25$4.59Dec 29, 25$4.35Jan 2, 26$5.11Jan 6, 26$5.88Jan 8, 26$5.35Jan 12, 26$5.36Jan 14, 26$5.22Jan 16, 26$5.42Jan 21, 26$5.43Jan 23, 26$5.17Jan 27, 26$5.40Jan 29, 26$5.22Feb 2, 26$5.01Feb 4, 26$4.81Feb 9, 26$4.86Feb 11, 26$4.92Feb 13, 26$4.88Feb 18, 26$4.08Feb 20, 26$4.08Feb 24, 26$4.18Feb 26, 26$4.14Mar 2, 26$4.00Mar 4, 26$4.74Mar 6, 26$5.06Mar 10, 26$4.76Mar 12, 26$4.73Mar 17, 26$4.39Mar 19, 26$4.35Mar 23, 26$4.62Mar 25, 26$4.62Mar 27, 26$4.40Mar 31, 26$4.66Apr 2, 26$4.77Apr 7, 26$4.98Apr 9, 26$4.43Apr 13, 26$4.50Apr 15, 26$4.44Apr 17, 26$4.84Apr 22, 26$5.11Apr 24, 26$4.76Apr 28, 26$4.75Apr 30, 26$4.70May 4, 26$4.49May 6, 26$4.30May 8, 26$4.76May 12, 26$4.39May 14, 26$4.60May 18, 26$4.53May 20, 26$4.09May 22, 26$3.69May 28, 26$3.72Jun 1, 26$3.72Jun 3, 26$3.47Jun 5, 26$3.44Jun 9, 26$3.39Jun 11, 26$3.24Jun 15, 26$3.32Jun 17, 26$3.31Jun 22, 26$3.25Jun 24, 26$3.27Jun 26, 26$3.34Jul 2, 26$3.00
$3.0052-week range$6.36
Loading valuation history…

Fundamentals

Key fundamentals

$32.5M

Market cap

250.3%

Revenue growth (YoY)

67.3%

Gross margin

-$2.9M

Free cash flow (USD)

-$6.3M

Net debt

Net cash position

50.0%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$0.00FY 2017$0.00FY 2018$0.00FY 2019$0.00FY 2020$1.9MFY 2021$178.1KFY 2022$171.2KFY 2023$2.0MFY 2024$3.5MFY 2025$12.1M
$0$12.1M

Free cash flow by year

2016 → 2025

FY 2016$-21.1KFY 2017$-2.2MFY 2018$-2.8MFY 2019$-5.5MFY 2020$-3.5MFY 2021$-8.7MFY 2022$-7.8MFY 2023$-13.3MFY 2024$-11.1MFY 2025$-2.9M
-$21.1K-$2.9M

Gross margin by year

2021 → 2025

FY 2021-54.9%FY 2022-41.4%FY 202323.4%FY 202431.3%FY 202567.3%
-54.9%67.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

1

Insider sells · 90 days

Earnings

Last report: 10-Q/A filed Jun 12, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $32KChristianson Mark · Market Development Director · $31.8KJul 2, 2026Filing
  • Quarterly report10-Q FiledJun 12, 2026Filing
  • 8-K eventProspectus Supplement FiledJun 12, 2026Filing
  • 8-K eventFinancial Statement RestatementMay 22, 2026Filing
  • 8-K eventEarnings ReleaseMay 12, 2026Filing
  • Quarterly report10-Q FiledMay 12, 2026Filing
  • 8-K eventRegained ComplianceMay 4, 2026Filing
  • 8-K eventCFO Transition AgreementApr 30, 2026Filing
  • 8-K eventReverse Stock SplitApr 14, 2026Filing
  • 8-K eventAnnual Meeting ResultsApr 3, 2026Filing

Questions

Frequently asked questions

What is NeuroOne Medical Technologies Corporation's market cap?

NeuroOne Medical Technologies Corporation (NMTC) has a market capitalization of $32.5M.

What is NMTC's P/E ratio?

A meaningful P/E ratio is not available for NMTC — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is NMTC's price-to-book (P/B) ratio?

NMTC trades at 4.60 times book value per share.

Are insiders buying NMTC stock?

SEC Form 4 filings show no open-market insider buys at NeuroOne Medical Technologies Corporation in the last 90 days (1 sell).

Same arena

Related companies in Medical - Devices

CTSO

Cytosorbents Corporation

$31M

POAS

Phaos Technology Holdings (Caym

$34.8M

PLSM

Pulsenmore Ltd. Ordinary Shares

$29.7M

MYO

Myomo, Inc.

$41.5M

TELA

TELA Bio, Inc.

$42.5M

NSPR

InspireMD, Inc.

$43.9M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.